CRISPR/Cas9 disruption of EpCAM Exon 2 results in cell-surface expression of a truncated protein targeted by an EpCAM specific T cell engager. - Bagheri A; Culp PA; DuBridge RB; Chen TT (Biochemistry and biophysics reports, 2022)